Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)

NCT01956279 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

FED

Sponsor class

Conditions

Fatigue
Musculoskeletal Pain
Cognitive Decline

Interventions

DRUG: Pregnenolone
DRUG: Placebo

Sponsor

VA Office of Research and Development